You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Dutasteride And Tamsulosin Hydrochloride, and what generic alternatives are available?

Dutasteride And Tamsulosin Hydrochloride is a drug marketed by Actavis Labs Fl Inc, Aurobindo Pharma, Endo Operations, and Zydus Pharms. and is included in four NDAs.

The generic ingredient in DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE is dutasteride; tamsulosin hydrochloride. There are eighteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the dutasteride; tamsulosin hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Dutasteride And Tamsulosin Hydrochloride

A generic version of DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE was approved as dutasteride; tamsulosin hydrochloride by ENDO OPERATIONS on February 26th, 2014.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE?
  • What are the global sales for DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE?
  • What is Average Wholesale Price for DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE?
Summary for DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE
Drug patent expirations by year for DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE
Recent Clinical Trials for DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Beth Israel Deaconess Medical CenterN/A
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)N/A
Ministry of Health, FrancePhase 3

See all DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE clinical trials

Pharmacology for DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE

US Patents and Regulatory Information for DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE dutasteride; tamsulosin hydrochloride CAPSULE;ORAL 202975-001 Nov 20, 2015 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Pharms DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE dutasteride; tamsulosin hydrochloride CAPSULE;ORAL 207769-001 May 24, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aurobindo Pharma DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE dutasteride; tamsulosin hydrochloride CAPSULE;ORAL 213300-001 Jul 18, 2024 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Endo Operations DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE dutasteride; tamsulosin hydrochloride CAPSULE;ORAL 202509-001 Feb 26, 2014 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.